Key facts
- This page summarizes Mark Mallon's Form 4 filing for NEOGENOMICS INC (NEO).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2022, 18:59.
Mark Mallon - 01 Mar 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- NEO
- Reported as of
- 01 Mar 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2022, 18:59:06 UTC
- Prior SEC filing
- 30 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Halley E. Gilbert, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark Mallon filed Form 4 for NEOGENOMICS INC (NEO) on 03 Mar 2022.
Change
- Previous filing in this sequence was filed on 30 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEO
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +142,457
- Change %
- +63%
- Price
- $0.000000
- Shares after
- 368,051
- Date
- 01 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NEO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +347,777
- Change %
- Price
- $0.000000
- Shares after
- 347,777
- Date
- 01 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 347,777
- Exercise price
- $21.41
- Footnotes
- F3
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 151,016
- Date
- 01 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 151,016
- Exercise price
- $49.34
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On March 1, 2022, Mr. Mallon was granted 142,457 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
Footnote F2
On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Footnote F3
On March 1, 2022, Mr. Mallon was granted 347,777 stock options. These options vest ratably over the first four anniversary dates of the grant date.
SEC remarks
Exhibit List: Exhibit 24 - Limited Power Of Attorney